151 related articles for article (PubMed ID: 31858289)
1. Spill-in counts in the quantification of
López-González FJ; Moscoso A; Efthimiou N; Fernández-Ferreiro A; Piñeiro-Fiel M; Archibald SJ; Aguiar P; Silva-Rodríguez J;
EJNMMI Phys; 2019 Dec; 6(1):27. PubMed ID: 31858289
[TBL] [Abstract][Full Text] [Related]
2. Impact of spill-in counts from off-target regions on [
López-González FJ; Costoya-Sánchez A; Paredes-Pacheco J; Moscoso A; Silva-Rodríguez J; Aguiar P;
Neuroimage; 2022 Oct; 259():119396. PubMed ID: 35753593
[TBL] [Abstract][Full Text] [Related]
3. Partial volume correction in longitudinal tau PET studies: is it really needed?
Costoya-Sánchez A; Moscoso A; Sobrino T; Ruibal Á; Grothe MJ; Schöll M; Silva-Rodríguez J; Aguiar P;
Neuroimage; 2024 Apr; 289():120537. PubMed ID: 38367651
[TBL] [Abstract][Full Text] [Related]
4. Quantitative
Zhao Q; Liu M; Ha L; Zhou Y;
Front Neurol; 2019; 10():486. PubMed ID: 31156534
[TBL] [Abstract][Full Text] [Related]
5. Parametric estimation of reference signal intensity in the quantification of amyloid-beta deposition: an
Wang M; Yan Z; Zhang H; Lu J; Li L; Yu J; Wang J; Matsuda H; Zuo C; Jiang J;
Quant Imaging Med Surg; 2021 Jan; 11(1):249-263. PubMed ID: 33392026
[TBL] [Abstract][Full Text] [Related]
6. The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease.
Thomas BA; Erlandsson K; Modat M; Thurfjell L; Vandenberghe R; Ourselin S; Hutton BF
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1104-19. PubMed ID: 21336694
[TBL] [Abstract][Full Text] [Related]
7. Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden.
Blautzik J; Brendel M; Sauerbeck J; Kotz S; Scheiwein F; Bartenstein P; Seibyl J; Rominger A;
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1364-1374. PubMed ID: 28326436
[TBL] [Abstract][Full Text] [Related]
8. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.
Landau SM; Fero A; Baker SL; Koeppe R; Mintun M; Chen K; Reiman EM; Jagust WJ
J Nucl Med; 2015 Apr; 56(4):567-74. PubMed ID: 25745095
[TBL] [Abstract][Full Text] [Related]
9. Reduced [
Moscoso A; Grothe MJ; Schöll M;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2283-2294. PubMed ID: 33475761
[TBL] [Abstract][Full Text] [Related]
10. Differences in gray and white matter
Son HJ; Oh JS; Roh JH; Seo SW; Oh M; Lee SJ; Oh SJ; Kim JS
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):357-366. PubMed ID: 30109402
[TBL] [Abstract][Full Text] [Related]
11. Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis.
Teipel SJ; Dyrba M; Vergallo A; Lista S; Habert MO; Potier MC; Lamari F; Dubois B; Hampel H; Grothe MJ
Front Aging Neurosci; 2021; 13():748198. PubMed ID: 35002673
[No Abstract] [Full Text] [Related]
12. Longitudinal Association between White Matter Hyperintensities and White Matter Beta-Amyloid Deposition in Cognitively Unimpaired Elderly.
Wang ML; Yu MM; Li WB; Li YH
Curr Alzheimer Res; 2021; 18(1):8-13. PubMed ID: 33761854
[TBL] [Abstract][Full Text] [Related]
13. Operationalizing the centiloid scale for [
Coath W; Modat M; Cardoso MJ; Markiewicz PJ; Lane CA; Parker TD; Keshavan A; Buchanan SM; Keuss SE; Harris MJ; Burgos N; Dickson J; Barnes A; Thomas DL; Beasley D; Malone IB; Wong A; Erlandsson K; Thomas BA; Schöll M; Ourselin S; Richards M; Fox NC; Schott JM; Cash DM;
Alzheimers Dement (Amst); 2023; 15(2):e12434. PubMed ID: 37201176
[TBL] [Abstract][Full Text] [Related]
14. Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region.
Chen K; Roontiva A; Thiyyagura P; Lee W; Liu X; Ayutyanont N; Protas H; Luo JL; Bauer R; Reschke C; Bandy D; Koeppe RA; Fleisher AS; Caselli RJ; Landau S; Jagust WJ; Weiner MW; Reiman EM;
J Nucl Med; 2015 Apr; 56(4):560-6. PubMed ID: 25745091
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Standardized Uptake Value Ratio Calculations in Amyloid Positron Emission Tomography Brain Imaging.
Knešaurek K; Warnock G; Kostakoglu L; Burger C;
World J Nucl Med; 2018; 17(1):21-26. PubMed ID: 29398961
[TBL] [Abstract][Full Text] [Related]
16. PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET.
Gonzalez-Escamilla G; Lange C; Teipel S; Buchert R; Grothe MJ;
Neuroimage; 2017 Feb; 147():669-677. PubMed ID: 28039094
[TBL] [Abstract][Full Text] [Related]
17. Quantification of 18F-florbetapir PET: comparison of two analysis methods.
Hutton C; Declerck J; Mintun MA; Pontecorvo MJ; Devous MD; Joshi AD;
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):725-32. PubMed ID: 25652817
[TBL] [Abstract][Full Text] [Related]
18. Comparison of [
Lowe VJ; Lundt E; Knopman D; Senjem ML; Gunter JL; Schwarz CG; Kemp BJ; Jack CR; Petersen RC
Neuroimage Clin; 2017; 16():295-302. PubMed ID: 28856092
[TBL] [Abstract][Full Text] [Related]
19. Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction.
Brendel M; Högenauer M; Delker A; Sauerbeck J; Bartenstein P; Seibyl J; Rominger A;
Neuroimage; 2015 Mar; 108():450-9. PubMed ID: 25482269
[TBL] [Abstract][Full Text] [Related]
20. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.
Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L
J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
